Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesBotsEarnCopy
Leading Biopharmaceutical Technology Surges Over 240% Intraday After Announcing Plans to Acquire Full Equity of Conflux

Leading Biopharmaceutical Technology Surges Over 240% Intraday After Announcing Plans to Acquire Full Equity of Conflux

View original
星球日报星球日报2025/07/02 02:59

Odaily Planet Daily reported that Hong Kong-listed company Leading Pharma-Biotech (00399) saw a surge in trading volume and a sharp rise in its share price during early trading today, with an intraday increase of nearly 240% and a peak price of HK$0.7, before retreating to around HK$0.34.
Previously, the company announced plans to acquire all equity in the blockchain project Conflux to expand its presence in the blockchain sector. Two founding members of Conflux currently serve as its executive directors.

0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

PoolX: Locked for new tokens.
APR up to 10%. Always on, always get airdrop.
Lock now!